Caprolactam Chemicals Hits 52-Week Low Amidst Strong Sell Rating and Bearish Trend
Caprolactam Chemicals, a microcap pharmaceutical and drug company, has hit a 52-week low on November 12, 2024, with a significant loss of -18.87%. The stock has been given a Strong Sell rating by MarketsMojo and has been underperforming the sector by -11.34%. It is currently trading below its moving averages and has a 1-year performance of -25.95%. Investors should carefully consider their options before making any decisions regarding this stock.
Caprolactam Chemicals, a microcap pharmaceutical and drug company, has recently hit a 52-week low on November 12, 2024. This news comes as the stock has been given a "Strong Sell" rating by MarketsMOJO.
The stock opened today with a significant loss of -18.87% and has continued to underperform the sector by -11.34%. In fact, the stock has been on a downward trend for the past two days, with a total loss of -11.49% during this period. The day's low for the stock was Rs. 43, which is also the new 52-week low.
Caprolactam Chemicals is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. In comparison to the Sensex performance of 21.95%, the company's 1-year performance has been -25.95%.
While the stock may be facing challenges in the market, it is important to note that this is a microcap company in the pharmaceutical and drug industry. As such, it may be more susceptible to market fluctuations and volatility. Investors should carefully consider their options before making any decisions regarding this stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
